The secretomes containing RANKL serve as a supplement of the cytokine to enhance the formation of tartrate-resistant acid phosphatase positive (TRAP+) cells in bone, yielding a potential treatment for osteopetrosis.40 Additional studies demonstrate the potential of cell-free therapies utilizing MSC secretomes. Here, ACP5 is linked to osteopetrosis.